Garuda Therapeutics Launches with $72 Million Series A Financing
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf, […]
News
2024
News
Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing
News
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company
News
Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1, 2021
LOCUST WALK NEWS Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1,
News
Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option PHILADELPHIA
News
LOCUST WALK ACQUISITION CORP. ANNOUNCES PRICING OF UPSIZED $153,000,000 INITIAL PUBLIC OFFERING
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Pricing of Upsized $153,000,000 Initial Public Offering PHILADELPHIA and BOSTON, Jan. 7,
Podcast
Biotalk Episode 15: 2024 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 11:03 — 25.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q1 Report: Global Trends in Biopharma Transactions Report. Each quarter,
Insight, Market Trends, Quarterly Reports
Overview of AI in Biotech
Locust Walk’s Overview of AI in Biotech report discusses how AI has profoundly impacted drug discovery and the pharmaceutical industry in the last five years, with AI-derived assets representing nearly half of the preclinical pipeline.
Uncategorized
Biotalk Episode 14: A Conversation with Kendalle Burlin O’Connell of MassBio
Podcast: Play in new window | Download (Duration: 35:36 — 81.5MB)
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Kendalle Burlin O’Connell, Esq., CEO and President of MassBio, the nation’s pioneering biotechnology trade
Podcast
Biotalk Episode 13: 2023 Year-In-Review Report: Global Trends in Biopharma Transactions
In this episode, Geoff provides valuable insights into our report, focusing on critical areas such as: We invite you to